Skip to content
  • About
  • Clinical Trials
  • Training
  • KRN-101
  • Investing
  • Contact
Menu
  • About
  • Clinical Trials
  • Training
  • KRN-101
  • Investing
  • Contact
CSE: ABRT • FSE: VB50
CSE: ABRT
ABRT
  • About
  • Clinical Trials
  • Training
  • KRN-101
  • Investing
  • Contact
Menu
  • About
  • Clinical Trials
  • Training
  • KRN-101
  • Investing
  • Contact
CSE: ABRT • FSE: VB50
CSE: ABRT
ABRT
Read more about the article Brexit Britain becomes unlikely psychedelic haven as Albert Labs IPOs

Brexit Britain becomes unlikely psychedelic haven as Albert Labs IPOs

  • Post author:Olly PP
  • Post published:March 10, 2022
  • Post category:Industry News

Continue ReadingBrexit Britain becomes unlikely psychedelic haven as Albert Labs IPOs
Read more about the article Persisting decreases in state and trait anxiety post-psilocybin: A naturalistic, observational study among retreat attendees

Persisting decreases in state and trait anxiety post-psilocybin: A naturalistic, observational study among retreat attendees

  • Post author:Olly PP
  • Post published:March 2, 2022
  • Post category:Industry News

Continue ReadingPersisting decreases in state and trait anxiety post-psilocybin: A naturalistic, observational study among retreat attendees
Read more about the article Harvard takes a new trip into the world of psychedelic drugs

Harvard takes a new trip into the world of psychedelic drugs

  • Post author:Olly PP
  • Post published:February 23, 2022
  • Post category:Industry News

Continue ReadingHarvard takes a new trip into the world of psychedelic drugs
Read more about the article After Its Vilification In The 1960s, There Is Now A Renaissance In Psychedelic Drugs To Help Treat Depression And Mental Health Issues

After Its Vilification In The 1960s, There Is Now A Renaissance In Psychedelic Drugs To Help Treat Depression And Mental Health Issues

  • Post author:Olly PP
  • Post published:February 19, 2022
  • Post category:Industry News

Continue ReadingAfter Its Vilification In The 1960s, There Is Now A Renaissance In Psychedelic Drugs To Help Treat Depression And Mental Health Issues
Read more about the article Psilocybin Treatment for Major Depression Effective for Up to a Year for Most Patients, Study Shows

Psilocybin Treatment for Major Depression Effective for Up to a Year for Most Patients, Study Shows

  • Post author:Olly PP
  • Post published:February 15, 2022
  • Post category:Industry News

Continue ReadingPsilocybin Treatment for Major Depression Effective for Up to a Year for Most Patients, Study Shows
Read more about the article Using Real-World Evidence to Accelerate Psychedelic Drug Development

Using Real-World Evidence to Accelerate Psychedelic Drug Development

  • Post author:Olly PP
  • Post published:February 9, 2022
  • Post category:News

Continue ReadingUsing Real-World Evidence to Accelerate Psychedelic Drug Development
Read more about the article What psychedelics has got right that the cannabis industry hasn’t
Dried psilocybe cubensis psilocybin mushrooms and cannabis leaf on white background, flat lay. Psychedelic experience. Natural herbal therapy. Spiritual experience.

What psychedelics has got right that the cannabis industry hasn’t

  • Post author:Olly PP
  • Post published:February 4, 2022
  • Post category:Industry News

Continue ReadingWhat psychedelics has got right that the cannabis industry hasn’t
Read more about the article Two thirds of physicians surveyed believe psilocybin therapy has potential benefit for patients with treatment-resistant depression
People Images/Getty Images

Two thirds of physicians surveyed believe psilocybin therapy has potential benefit for patients with treatment-resistant depression

  • Post author:Olly PP
  • Post published:January 19, 2022
  • Post category:Industry News

Continue ReadingTwo thirds of physicians surveyed believe psilocybin therapy has potential benefit for patients with treatment-resistant depression
Read more about the article Psychedelics ‘Train Has Left the Station’ Says Federal Drug Official as More States Seek Access

Psychedelics ‘Train Has Left the Station’ Says Federal Drug Official as More States Seek Access

  • Post author:Olly PP
  • Post published:January 18, 2022
  • Post category:Industry News

Continue ReadingPsychedelics ‘Train Has Left the Station’ Says Federal Drug Official as More States Seek Access
Read more about the article Virginia Lawmakers Propose Decriminalizing Psychedelic Mushrooms

Virginia Lawmakers Propose Decriminalizing Psychedelic Mushrooms

  • Post author:Olly PP
  • Post published:January 14, 2022
  • Post category:Industry News

Continue ReadingVirginia Lawmakers Propose Decriminalizing Psychedelic Mushrooms
  • Go to the previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Go to the next page

Recent Posts

  • Albert Labs Welcomes Dr. Shabir Hasham to Board of Directors
  • Albert Labs Management and Board of Director Announcement
  • Albert Labs Receives preliminary acceptance of 35 Novel Inventive Claims for Patent Protected Manufacturing Technology
  • Expansion of Drug Discovery and a Promising Pipeline
  • Albert Labs Announces Private Placement

Recent Comments

  • Randal Elliott on Another Psychedelics Company Goes Public: Albert Labs To List On CSE, Appoints Chrystal Capital As UK Banker
  • Nicholas Stewart on Another Psychedelics Company Goes Public: Albert Labs To List On CSE, Appoints Chrystal Capital As UK Banker
  • Camille Ortega on Another Psychedelics Company Goes Public: Albert Labs To List On CSE, Appoints Chrystal Capital As UK Banker
  • Kelly Lambert on Another Psychedelics Company Goes Public: Albert Labs To List On CSE, Appoints Chrystal Capital As UK Banker
  • Dean Phillips on Another Psychedelics Company Goes Public: Albert Labs To List On CSE, Appoints Chrystal Capital As UK Banker

Innovative mental health medicines for patients with unmet needs

  • Legal Disclaimer
  • Privacy Policy
  • Modern Slavery Statement
  • Cookie Policy
  • Legal Disclaimer
  • Privacy Policy
  • Modern Slavery Statement
  • Cookie Policy

© 2024 Albert Labs. All Rights Reserved

  • About
  • Clinical Trials
  • Training
  • KRN-101
  • Investing
  • Contact
  • About
  • Clinical Trials
  • Training
  • KRN-101
  • Investing
  • Contact
Twitter Linkedin Youtube Envelope
CSE:ABRT
FSE: VB50
CSE:ABRT
FSE: VB50

About Albert Labs

We are a pharmaceutical company leveraging our drug development and clinical research expertise to accelerate the development of highly effective mental health medicines.

If you would like support or more information around making an investment, please contact [email protected]

Twitter Linkedin Youtube Envelope

Complete this form to receive corporate updates and further details on how to invest in Albert Labs. By completing this form, you agree to our privacy policy.

  • This field is for validation purposes and should be left unchanged.
Twitter
Youtube
Linkedin
Instagram
Envelope
Twitter
Youtube
Linkedin
Instagram
Envelope

Latest Press Release

Albert Labs Welcomes Dr. Shabir Hasham to Board of Directors

Read more

By completing this form you agree to our privacy policy. You will be sent corporate updates and further details including how to invest in Albert Labs.